Friday, 29 March 2024
Catabasis Pharmaceuticals Inc
NASDAQ : CATB
8.540 08 Sep 21 00:00 | Change: 0.64 | Open: 9.210 | High: 9.210 | Ask: 0.000 | Volume: 98,800 |
Change(%): 6.97 | Prev: 9.180 | Low: 8.460 | Bid: 0.000 | Avg vol: 0 |
19:45 | 1/3/18
Frisco Fastball
Analysts expect Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB) to report $-0.31 EPS on March, 15.They anticipate $0.16 EPS change or 34.04 % from last quarter's $-0.47 EPS.
more»
23:18 | 28/2/18
Wall Street Morning
On Tuesday, Catabasis Pharmaceuticals, Inc. (CATB) made the way into the market negative movers list with falling -2.86%.
more»
05:41 | 28/2/18
Post Analyst
Catabasis Pharmaceuticals, Inc. is maintained at an average buy rating by 3 stock analysts, and there are at least 0.25% of shares outstanding that are currently legally short sold.
more»
20:18 | 27/2/18
Frisco Fastball
Analysts expect Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB) to report $-0.31 EPS on March, 15.They anticipate $0.16 EPS change or 34.04 % from last quarter's $-0.47 EPS.
more»
This is a real time view of the critical technical pivot points for Catabasis Pharmaceuticals Inc (NASDAQ:CATB) . The technical pivot points we look at all surround the stock price movement from the last 10-trading days through the last year.
more»
There are currently no comments on this topic.
Be the first person to Add a Comment...
You must be a registered user to post a comment: REGISTER NOW
If you are already registered, please LOGIN NOW
|
Code | Last | Change |
COMP | 10,321 | 328 | | 3.08% |
DJI | 29,635 | 404 | | 1.34% |
SP500 | 3,583 | 87 | | 2.37% |
DAX | 12,438 | 82 | | 0.67% |
FTSE | 7,488 | 5 | | 0.07% |
NI225 | 22,420 | 408 | | 1.86% |
TWI | 67.27 | 0.00 | | 0.00% |